Literature DB >> 20177752

Tobacco use: a chronic illness?

Naomi L Hudson1, David M Mannino.   

Abstract

Tobacco use is a modifiable risk factor that has many characteristics of a chronic illness. We analyzed longitudinal data from participants in the Atherosclerosis Risk in Communities Study (ARIC) and the Cardiovascular Health Study (CHS) and compared tobacco use to other chronic illnesses to evaluate effects on mortality. We limited our analysis to 20,293 participants aged 45 and older at baseline. We determined smoking status, diabetes status, hypertension, cardiovascular disease (ASCVD), and lung disease status at baseline. We developed Cox proportional hazard models, adjusting for age, sex and race and all comorbid diseases, to determine the effect of disease on mortality at up to 13 years of follow-up, 3,022 study participants died during the follow-up period. Adjusted proportional hazard models found that the risk of smoking for death had a hazard ratio (HR) of 2.0 (95% confidence interval [CI] 1.8, 2.2). This was similar to the mortality risk for ASCVD (HR 1.8, 95% CI 1.7, 2.0), diabetes (HR 1.9, 95% CI 1.7, 2.0), and chronic obstructive pulmonary disease (COPD) (HR 2.1, 95% CI 1.9, 2.4). The risk in former smokers were significantly less than that of current smokers (HR 1.1, 95% CI 1.01, 1.2). In the adjusted models, current cigarette smoking has a mortality risk that is in the same range of that seen in other "chronic diseases", whereas the risk in former smokers is greatly reduced. These data suggest that current smoking should be approached as aggressively as other chronic diseases that are amenable to interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20177752     DOI: 10.1007/s10900-010-9241-x

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  17 in total

1.  Factors associated with successful smoking cessation in the United States, 2000.

Authors:  Chung-won Lee; Jennifer Kahende
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

2.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Authors:  Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett
Journal:  Ann Intern Med       Date:  2005-02-15       Impact factor: 25.391

3.  Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Keattiyoat Wattanakit; Aaron R Folsom; Lloyd E Chambless; F Javier Nieto
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

4.  Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.

Authors:  L H Kuller; P Velentgas; J Barzilay; N J Beauchamp; D H O'Leary; P J Savage
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

5.  Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning.

Authors:  Mieke Rijken; Marion van Kerkhof; Joost Dekker; François G Schellevis
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

6.  Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease.

Authors:  R Li; E Boerwinkle; A F Olshan; L E Chambless; J S Pankow; H A Tyroler; M Bray; G S Pittman; D A Bell; G Heiss
Journal:  Atherosclerosis       Date:  2000-04       Impact factor: 5.162

7.  Impaired lung function and subclinical atherosclerosis. The ARIC Study.

Authors:  Emily B Schroeder; Verna Lamar Welch; Gregory W Evans; Gerardo Heiss
Journal:  Atherosclerosis       Date:  2005-01-25       Impact factor: 5.162

8.  Indicators for chronic disease surveillance.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2004-09-10

9.  Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes.

Authors:  Andrew F Olshan; Rongling Li; James S Pankow; Molly Bray; Herman A Tyroler; Lloyd E Chambless; Eric Boerwinkle; Gary S Pittman; Douglas A Bell
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

10.  Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study.

Authors:  P L Enright; R A Kronmal; M W Higgins; M B Schenker; E F Haponik
Journal:  Chest       Date:  1994-09       Impact factor: 9.410

View more
  9 in total

1.  α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling.

Authors:  Mohammad Kamrul Hasan; Theodore C Friedman; Carl Sims; Desean L Lee; Jorge Espinoza-Derout; Adaku Ume; Victor Chalfant; Martin L Lee; Indrani Sinha-Hikim; Kabirullah Lutfy; Yanjun Liu; Sushil K Mahata; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

2.  Tobacco Use Disorder Among Patients With Smoking-related Chronic Medical Disease: Association With Comorbid Substance Use Disorders.

Authors:  Ajay Manhapra; Robert Rosenheck
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

3.  Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.

Authors:  Ayaka Hamabe; Hirofumi Uto; Yasushi Imamura; Ken Kusano; Seiichi Mawatari; Kotaro Kumagai; Takeshi Kure; Tsutomu Tamai; Akihiro Moriuchi; Toshio Sakiyama; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2011-02-08       Impact factor: 7.527

4.  Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis.

Authors:  Indrani Sinha-Hikim; Theodore C Friedman; Mark Falz; Victor Chalfant; Mohammad Kamrul Hasan; Jorge Espinoza-Derout; Desean L Lee; Carl Sims; Peter Tran; Sushil K Mahata; Amiya P Sinha-Hikim
Journal:  Cell Tissue Res       Date:  2016-12-05       Impact factor: 5.249

5.  Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.

Authors:  Theodore C Friedman; Indrani Sinha-Hikim; Meher Parveen; Sonia M Najjar; Yanjun Liu; Michael Mangubat; Chang-Sung Shin; Alexei Lyzlov; Rasheed Ivey; Magda Shaheen; Samuel W French; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2012-10-23       Impact factor: 4.736

6.  Nicotine in combination with a high-fat diet causes intramyocellular mitochondrial abnormalities in male mice.

Authors:  Indrani Sinha-Hikim; Theodore C Friedman; Chang-Sung Shin; Desean Lee; Rasheed Ivey; Amiya P Sinha-Hikim
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

7.  Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling.

Authors:  R Ivey; M Desai; K Green; I Sinha-Hikim; T C Friedman; A P Sinha-Hikim
Journal:  Horm Metab Res       Date:  2014-05-15       Impact factor: 2.936

Review 8.  Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights.

Authors:  Amiya P Sinha-Hikim; Indrani Sinha-Hikim; Theodore C Friedman
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-10       Impact factor: 5.555

9.  Addressing Smoking Cessation among Women in Substance Use Treatment: A Qualitative Approach to Guiding Tailored Interventions.

Authors:  Isabel Martinez Leal; Matthew Taing; Virmarie Correa-Fernández; Ezemenari M Obasi; Bryce Kyburz; Kathy Le; Litty Koshy; Tzuan A Chen; Teresa Williams; Kathleen Casey; Daniel P O'Connor; Lorraine R Reitzel
Journal:  Int J Environ Res Public Health       Date:  2021-05-27       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.